Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Clinical Trial To Evaluate ANT-1207 In Subjects With Acne

ClinicalTrials.gov ID: NCT01293552

Public ClinicalTrials.gov record NCT01293552. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 5:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to provide evidence of the safety, tolerance, and efficacy of ANT-1207 in the treatment of acne.

Study identification

NCT ID
NCT01293552
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Anterios Inc.
Industry
Enrollment
72 participants

Conditions and interventions

Conditions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2010
Primary completion
Mar 31, 2012
Completion
Jun 30, 2012
Last update posted
Jul 3, 2013

2011 – 2012

United States locations

U.S. sites
15
U.S. states
12
U.S. cities
15
Facility City State ZIP Site status
Total Skin & Beauty Dermatology Center Birmingham Alabama 35205
International Dermatology Research Miami Florida 33144
Palm Beach Esthetic Dermatology and Laser Center West Palm Beach Florida 33401
Gwinnett Clinical Research Center Inc. Snellville Georgia 30078
Dermatology Specialists Research, LLC Louisville Kentucky 40202
William Coleman III, MD, APMC Metairie Louisiana 70006
Grekin Skin Institute Warren Michigan 48088
The Dermatology Group, P.C. Verona New Jersey 07044
Gramercy Park Dermatology New York New York 10010
Skin Search of Rochester, Inc Rochester New York 14623
Dermatology Consulting Services High Point North Carolina 27262
Penn State Hershey Medical Center Department of Dermatology Hershey Pennsylvania 17033
Yardley Dermatology Associates Yardley Pennsylvania 19067
The Skin Wellness Center Knoxville Tennessee 37922
DermResearch, Inc. Austin Texas 78759

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01293552, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 3, 2013 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01293552 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →